Research Output per year
Research Output 1994 2019
- 1 - 50 out of 649 results
- Publication Year, Title (descending)
2019
A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study
Stefanutti, C., Pang, J., Di Giacomo, S., Wu, X., Wang, X., Morozzi, C., Watts, G. F. & Lin, J., 12 May 2019, In : Journal of Clinical Lipidology.Research output: Contribution to journal › Article
Hyperlipoproteinemia Type II
Blood Component Removal
LDL Cholesterol
Survival
Lipoproteins
A window into the heart of familial hypercholesterolaemia in the community
Watts, G. F. & Pang, J., 1 May 2019, In : The Lancet Public Health. 4, 5, p. e216-e217Research output: Contribution to journal › Editorial
Open Access
Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies
Ward, N. C., Page, M. M. & Watts, G. F., 1 Apr 2019, In : Diabetes, Obesity and Metabolism. 21, S1, p. 52-62 11 p.Research output: Contribution to journal › Article
LDL Cholesterol
Monoclonal Antibodies
Cardiovascular Diseases
Guidelines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
Citations
(Scopus)
Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”
Pang, J., Chan, D. C., Hu, M., Muir, L. A., Kwok, S., Charng, M. J., Florkowski, C. M., George, P. M., Lin, J., Loi, D. D., Marais, A. D., Nawawi, H. M., Gonzalez-Santos, L. E., Su, T. C., Truong, T. H., Santos, R. D., Soran, H., Tomlinson, B., Yamashita, S., Ademi, Z. & 1 others, Apr 2019, In : Journal of Clinical Lipidology. 13, 2, p. 287-300Research output: Contribution to journal › Article
Hyperlipoproteinemia Type II
Delivery of Health Care
Genetic Testing
Education
Developing Countries
Dyslipidaemia in adults with type 1 diabetes-when to treat?
Lan, N. S. R., Fegan, P. G., Yeap, B. B., Bell, D. A. & Watts, G. F., Jan 2019, In : Diabetes/Metabolism Research and Reviews. 35, 1, 5 p., 3090.Research output: Contribution to journal › Editorial
Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does it Make a Difference in the Clinic?
Chan, D. C., Pang, J., Hooper, A. J., Bell, D. A., Burnett, J. R. & Watts, G. F., 2019, In : Clinical Chemistry. p. clinchem.2019.306738Research output: Contribution to journal › Article
Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies
Pirro, M., Simental-Mendia, L. E., Bianconi, V., Watts, G. F., Banach, M. & Sahebkar, A., Jan 2019, In : Journal of Clinical Medicine. 8, 1, 14 p., 118.Research output: Contribution to journal › Review article
Open Access
Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration
Ma, L., Chan, D. C., Ooi, E. M. M., Barrett, P. H. R. & Watts, G. F., 1 Jul 2019, In : Metabolism: clinical and experimental. 96, p. 8-11 4 p.Research output: Contribution to journal › Article
Apolipoprotein B-100
Apoprotein(a)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Apolipoproteins B
Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it
Lan, N. S. R., Fegan, P. G., Yeap, B. B., Rankin, J. M. & Watts, G. F., 1 Jul 2019, In : Diabetes, Obesity and Metabolism. 21, 7, p. 1734-1736 3 p.Research output: Contribution to journal › Article
Dyslipidemias
Coronary Artery Disease
Acute Coronary Syndrome
Cardiovascular Diseases
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Identifying Perceptions and Preferences of the General Public Concerning Universal Screening of Children for Familial Hypercholesterolaemia
Bowman, F. L., Molster, C. M., Lister, K. J., Bauskis, A. T., Garton-Smith, J., Vickery, A. W., Watts, G. F. & Martin, A. C., 22 Jul 2019, In : Public Health Genomics.Research output: Contribution to journal › Article
Open Access
Hyperlipoproteinemia Type II
Inborn Genetic Diseases
Genomics
Coronary Disease
Immunization
2
Citations
(Scopus)
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy
Warden, B. A., Minnier, J., Watts, G. F., Fazio, S. & Shapiro, M. D., 26 Apr 2019, In : Journal of Clinical Lipidology.Research output: Contribution to journal › Article
Lipoprotein(a)
Niacin
Group Psychotherapy
Therapeutics
Proprotein Convertase 9
Implementing simple algorithms to improve glucose and lipid management in people with diabetes and acute coronary syndrome
Lan, N. S. R., Fegan, P. G., Rankin, J. M., Bell, D. A., Watts, G. F. & Yeap, B. B., 31 Jul 2019, In : Diabetic Medicine. 9 p.Research output: Contribution to journal › Article
Acute Coronary Syndrome
Prescriptions
Symporters
Lipids
Blood Glucose
Improving the detection of familial hypercholesterolaemia
Lan, N. S. R., Martin, A. C., Brett, T., Watts, G. F. & Bell, D. A., Feb 2019, In : Pathology. 51, 2, p. 213-221 9 p.Research output: Contribution to journal › Review article
Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease
Ma, L., Waldmann, E., Ooi, E. M. M., Chan, D. C., Barrett, H. P. R., Watts, G. F. & Parhofer, K. G., Feb 2019, In : European Journal of Clinical Investigation. 49, 2, p. e13053Research output: Contribution to journal › Article
Blood Component Removal
Lipoprotein(a)
Apolipoproteins B
LDL Lipoproteins
Metabolism
Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia
Vuorio, A., Watts, G. F. & Kovanen, P. T., Feb 2019, In : Atherosclerosis. 281, p. 25-30 6 p.Research output: Contribution to journal › Review article
1
Citation
(Scopus)
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy
Chan, D. C., Watts, G. F., Coll, B., Wasserman, S. M., Marcovina, S. M. & Barrett, P. H. R., 2 Apr 2019, In : Journal of the American Heart Association. 8, 7, p. e011781Research output: Contribution to journal › Article
Open Access
Apoprotein(a)
Lipoprotein(a)
Protein Isoforms
Cholesterol
Therapeutics
Loneliness in psychotic illness and its association with cardiometabolic disorders
Badcock, J. C., Mackinnon, A., Waterreus, A., Watts, G. F., Castle, D., McGrath, J. J. & Morgan, V. A., Feb 2019, In : Schizophrenia Research. 204, p. 90-95 6 p.Research output: Contribution to journal › Article
PCSK9 inhibition 2018: riding a new wave of coronary prevention
Ward, N. C., Page, M. M. & Watts, G. F., 31 Jan 2019, In : Clinical Science. 133, 2, p. 205-224 20 p.Research output: Contribution to journal › Review article
2
Citations
(Scopus)
PCSK9 in HIV infection: New opportunity or red herring?
Ruscica, M., Watts, G. F. & Sirtori, C. R., 1 May 2019, In : Atherosclerosis. 284, p. 216-217 2 p.Research output: Contribution to journal › Editorial
PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies
Ruscica, M., Watts, G. F. & Sirtori, C. R., Jun 2019, In : European Journal of Preventive Cardiology. 26, 9, p. 998-1000 3 p.Research output: Contribution to journal › Editorial
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia
Pérez de Isla, L., Ray, K. K., Watts, G. F., Santos, R. D., Alonso, R., Muñiz-Grijalvo, O., Diaz-Diaz, J. L., Badimon, L., Catapano, A. L. & Mata, P., 1 Jul 2019, In : Atherosclerosis. 286, p. 40-45 6 p.Research output: Contribution to journal › Article
Hyperlipoproteinemia Type II
Monoclonal Antibodies
LDL Cholesterol
Numbers Needed To Treat
Therapeutics
Recent advances in synthetic pharmacotherapies for dyslipidaemias
Sirtori, C. R., Yamashita, S., Francesca Greco, M., Corsini, A., F Watts, G. & Ruscica, M., 6 May 2019, In : European Journal of Preventive Cardiology.Research output: Contribution to journal › Review article
Dyslipidemias
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertriglyceridemia
Drug Therapy
Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials
Lipid Blood Pressure Meta-Anal & ILEP, May 2019, In : Pharmacological Research. 143, p. 1-16 16 p.Research output: Contribution to journal › Review article
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH
Santos, R. D. & Watts, G. F., Feb 2019, In : Atherosclerosis. 281, p. 145-147 3 p.Research output: Contribution to journal › Editorial
6
Citations
(Scopus)
Statin Toxicity
Ward, N. C., Watts, G. F. & Eckel, R. H., 18 Jan 2019, In : Circulation Research. 124, 2, p. 328-350 23 p.Research output: Contribution to journal › Article
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscles
Primary Prevention
Secondary Prevention
LDL Cholesterol
1
Citation
(Scopus)
The effects of omega-3 fatty acid supplementation upon interleukin-12 and interleukin-18 in chronic kidney disease patients
Yong, K., Mori, T., Chew, G., Beilin, L. J., Puddey, I., Watts, G. F., Irish, A., Dogra, G., Boudville, N. & Lim, W., 2019, In : Journal of Renal Nutrition. 9 p.Research output: Contribution to journal › Article
Interleukin-18
Omega-3 Fatty Acids
Interleukin-12
Chronic Renal Insufficiency
C-Reactive Protein
The relationship between pulse pressure and inflammation with left ventricular diastolic dysfunction in chronic kidney disease patients
Yong, K., Mori, T., Chew, G., Beilin, L. J., Puddey, I., Watts, G., Dogra, G., Boudville, N. & Lim, W., 12 Feb 2019, In : Internal Medicine Journal. 49, 2, p. 240-247Research output: Contribution to journal › Article
Left Ventricular Dysfunction
Chronic Renal Insufficiency
Interleukin-18
Interleukin-12
Blood Pressure
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Fruchart, J-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Despres, J-P., Duriez, P., Eckel, R. H., Ezhov, M. V., Farnier, M., Ginsberg, H. N., Hermans, M. P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W. & 35 others, 4 Jun 2019, In : Cardiovascular Diabetology. 18, 1, 20 p., 71.Research output: Contribution to journal › Review article
Open Access
To test, or not to test: that is the question for the future of lipoprotein(a)
Ellis, K. L., Chakraborty, A., Moses, E. K. & Watts, G. F., 3 Apr 2019, In : Expert Review of Cardiovascular Therapy. 17, 4, p. 241-250 10 p.Research output: Contribution to journal › Review article
Lipoprotein(a)
Cardiovascular Diseases
Guidelines
Genetically Modified Animals
Expert Testimony
3
Citations
(Scopus)
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
Ellis, K. L., Pérez de Isla, L., Alonso, R., Fuentes, F., Watts, G. F. & Mata, P., 12 Mar 2019, In : Journal of the American College of Cardiology. 73, 9, p. 1029-1039 11 p.Research output: Contribution to journal › Article
Hyperlipoproteinemia Type II
Lipoprotein(a)
Cardiovascular Diseases
What's new on therapies for elevated lipoprotein(a)
Ward, N. C., Schultz, C. J. & Watts, G. F., 3 Jun 2019, In : Expert Review of Clinical Pharmacology. 12, 6, p. 495-499 5 p.Research output: Contribution to journal › Editorial
Lipoprotein(a)
Software
Molecular Sequence Annotation
Protein Databases
Peptides
2018
A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia
Chan, D. C., Pang, J., Hooper, A. J., Bell, D. A., Bates, T. R., Burnett, J. R. & Watts, G. F., 1 Apr 2018, In : The Journal of clinical endocrinology and metabolism. 103, 4, p. 1704-1714Research output: Contribution to journal › Article
Open Access
File
Hyperlipoproteinemia Type II
Lipids
Mutation
Early Diagnosis
Xanthomatosis
Acute Impact of Different Exercise Modalities on Arterial and Platelet Function
Haynes, A., Linden, M. D., Robey, E., Watts, G. F., Barrett, P. H. R., Naylor, L. H. & Green, D. J., 1 Apr 2018, In : Medicine & Science in Sports & Exercise. 50, 4, p. 785–791Research output: Contribution to journal › Article
Blood Platelets
Exercise
Platelet Activation
Brachial Artery
Acute Coronary Syndrome
6
Citations
(Scopus)
Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey
Banach, M., Mazidi, M., Mikhailidis, D. P., Toth, P. P., Jozwiak, J., Rysz, J. & Watts, G. F., 21 Oct 2018, In : European Heart Journal. 39, 40, p. 3635-3640 6 p.Research output: Contribution to journal › Article
Open Access
Hyperlipoproteinemia Type II
Telomere
Confidence Intervals
Nutrition Surveys
Lipids
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
Chan, D. C., Watts, G. F., Somaratne, R., Wasserman, S. M., Scott, R. & Barrett, P. H. R., Jul 2018, In : Arteriosclerosis, thrombosis, and vascular biology. 38, 7, p. 1644-1655 12 p.Research output: Contribution to journal › Article
Open Access
Apolipoprotein B-48
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoproteins
Triglycerides
Apolipoprotein B-100
Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics
Watts, G. F., Chan, D. C., Somaratne, R., Wasserman, S. M., Scott, R., Marcovina, S. M. & Barrett, P. H. R., 14 Jul 2018, In : European Heart Journal. 39, 27, p. 2577-2585 9 p.Research output: Contribution to journal › Article
Lipoprotein(a)
Apoprotein(a)
AMG 145
Proprotein Convertase 9
Apolipoproteins B
Dyslipidemia
Chan, D. T., Irish, A. B. & Watts, G. F., 1 Jan 2018, Handbook of Chronic Kidney Disease Management. 2nd ed. Kluwer Academic Publishers, p. 192-216 25 p.Research output: Chapter in Book/Conference paper › Chapter
Editorial introductions (in Current Opinion in Lipidology)
Stroes, E. S. G. & Watts, G. F., Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-433 1 p.Research output: Contribution to journal › Editorial
12
Citations
(Scopus)
Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Cicero, A. F. G., Pirro, M., Watts, G. F., Mikhailidis, D. P., Banach, M. & Sahebkar, A., 1 Jan 2018, In : Drugs. 78, 1, p. 99-109 11 p.Research output: Contribution to journal › Review article
Allopurinol
Meta-Analysis
Dilatation
Randomized Controlled Trials
Placebos
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 493-501 9 p.Research output: Contribution to journal › Article
Hyperlipoproteinemia Type II
Therapeutics
Cross-Sectional Studies
Cholesterol
Demography
Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis
Ellis, K. L., Pang, J., Chieng, D., Bell, D. A., Burnett, J. R., Schultz, C. J., Hillis, G. S. & Watts, G. F., Mar 2018, In : Clinical Cardiology. 41, 3, p. 378-384Research output: Contribution to journal › Article
Coronary Care Units
Hyperlipoproteinemia Type II
Lipoprotein(a)
Coronary Artery Disease
Acute Coronary Syndrome
Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease
Chieng, D., Pang, J., Ellis, K. L., Hillis, G. S., Watts, G. F. & Schultz, C. J., 3 Apr 2018, In : Journal of Clinical Lipidology. 12, 4, p. 1019-1026Research output: Contribution to journal › Article
Lipoprotein(a)
LDL Cholesterol
Coronary Artery Disease
Coronary Care Units
Hyperlipoproteinemia Type II
1
Citation
(Scopus)
Fenofibrate effects on carotid artery intima-media thickness in adults with type 2 diabetes mellitus: A FIELD substudy
Harmer, J. A., Keech, A. C., Veillard, A. S., Skilton, M. R., Watts, G. F. & Celermajer, D. S., 1 Jul 2018, In : Diabetes Research and Clinical Practice. 141, p. 156-167 12 p.Research output: Contribution to journal › Article
Fenofibrate
Carotid Intima-Media Thickness
Carotid Arteries
Type 2 Diabetes Mellitus
Dyslipidemias
Health literacy in familial hypercholesterolemia: A cross-national study
Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Jun 2018, In : European Journal of Cardiovascular Prevention & Rehabilitation. 25, 9, p. 936-943Research output: Contribution to journal › Article
Open Access
File
Health Literacy
Hyperlipoproteinemia Type II
China
Malaysia
Hong Kong
Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice
Pang, J., David Marais, A., Blom, D. J., Brice, B. C., Silva, P. R., Jannes, C. E., Pereira, A. C., Hooper, A. J., Ray, K. K., Santos, R. D. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 470-476 7 p.Research output: Contribution to journal › Article
South Australia
Hyperlipoproteinemia Type II
South Africa
Brazil
Life Style
Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families
Truong, T. H., Kim, N. T., Nguyen, M. N. T., Pang, J., Hooper, A. J., Watts, G. F. & Do, D. L., Oct 2018, In : Atherosclerosis. 277, p. 392-398 7 p.Research output: Contribution to journal › Article
Hyperlipoproteinemia Type II
Vietnam
Genetic Testing
LDL Receptors
Mutation
1
Citation
(Scopus)
Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
Sahebkar, A., Simental-Mendía, L. E., Pirro, M., Banach, M., Watts, G. F., Sirotri, C., Al-Rasadi, K. & Atkin, S. L., 1 Dec 2018, In : Scientific Reports. 8, 1, 17887.Research output: Contribution to journal › Article
Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Meta-Analysis
Randomized Controlled Trials
Placebos
1
Citation
(Scopus)
Improving the global care of familial hypercholesterolaemia: Starting the ball rolling
Ray, K. K. & Watts, G. F., 1 Oct 2018, In : Atherosclerosis. 277, p. 230-233 4 p.Research output: Contribution to journal › Editorial
3
Citations
(Scopus)
In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification
Bellinge, J. W., Francis, R. J., Majeed, K., Watts, G. F. & Schultz, C. J., 10 Jul 2018, In : Journal of Nuclear Cardiology. 25, 5, p. 1774-1783Research output: Contribution to journal › Review article
Sodium Fluoride
Positron-Emission Tomography
Cardiovascular Diseases
Vascular Calcification
Calcium
6
Citations
(Scopus)
Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions
Penson, P. E., Mancini, G. B. J., Toth, P. P., Martin, S. S., Watts, G. F., Sahebkar, A., Mikhailidis, D. P. & Banach, M., 1 Dec 2018, In : Journal of Cachexia, Sarcopenia and Muscle. 9, 6, p. 1023-1033 11 p.Research output: Contribution to journal › Article
Open Access
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Nocebo Effect
Muscles
Placebo Effect
Myalgia